![Tord Labuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tord Labuda
Verkställande Direktör på
ALZINOVA AB
Profil
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024.
Formerly, Dr. Labuda was Independent Director at NanoEcho AB from 2023 to 2026 and Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Aktiva positioner av Tord Labuda
| Företag | Position | Start |
|---|---|---|
| ALZINOVA AB | Verkställande Direktör | 2024-10-01 |
Tidigare kända positioner av Tord Labuda
| Företag | Position | Slut |
|---|---|---|
| NANOECHO AB | Direktör/Styrelseledamot | 2026-05-28 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Företagsledare/Principal | 2023-01-01 |
Tord Labudas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
57
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
